Latest news and press releases about CONMED Corporation (CNMD): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors.
Price
| Price | $46.32 |
| Market Cap | $1.4B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 25.01 |
| Price / Book | 1.27 |
| EV / EBITDA | 12.11 |
| Dividend Yield | 0.45% |
Profitability
| Return on Equity | 5.51% |
| Return on Invested Capital | 4.97% |
| Return on Assets | 2.46% |
| Gross Margin | 54.80% |
| Operating Margin | 10.79% |
| Net Margin | 4.12% |
Related companies: AHCO · AZTA · ESTA · INMD · KMTS · NEOG · NTLA
Explore sector: Healthcare · Medical - Devices
More sections of CNMD: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks